Skip NavigationSkip to Content

KIR2DL2 Enhances Protective and Detrimental HLA Class I-Mediated Immunity in Chronic Viral Infection

  1. Author:
    al Basatena, N. K. S.
    MacNamara, A.
    Vine, A. M.
    Thio, C. L.
    Astemborski, J.
    Usuku, K.
    Osame, M.
    Kirk, G. D.
    Donfield, S. M.
    Goedert, J. J.
    Bangham, C. R. M.
    Carrington, M.
    Khakoo, S. I.
    Asquith, B.
  2. Author Address

    [al Basatena, NKS; MacNamara, A; Vine, AM; Bangham, CRM; Khakoo, SI; Asquith, B] Univ London Imperial Coll Sci Technol & Med, London, England. [Thio, CL; Astemborski, J; Kirk, GD] Johns Hopkins Univ, Baltimore, MD USA. [Usuku, K] Kumamoto Univ, Kumamoto, Japan. [Osame, M] Kagoshima Univ, Kagoshima 890, Japan. [Donfield, SM] Rho, Chapel Hill, NC USA. [Goedert, JJ] NCI, Rockville, MD USA. [Carrington, M] SAIC Frederick Inc, NCI Frederick, Canc & Inflammat Program, Expt Immunol Lab, Frederick, MD USA. [Carrington, M] MIT, Ragon Inst MGH, Boston, MA USA. [Carrington, M] Harvard Univ, Boston, MA 02115 USA.;al Basatena, NKS (reprint author), Univ London Imperial Coll Sci Technol & Med, London, England;b.asquith@ic.ac.uk
    1. Year: 2011
    2. Date: Oct
  1. Journal: Plos Pathogens
    1. 7
    2. 10
    3. Pages: 12
  2. Type of Article: Article
  3. Article Number: e1002270
  4. ISSN: 1553-7366
  1. Abstract:

    Killer cell immunoglobulin-like receptors (KIRs) influence both innate and adaptive immunity. But while the role of KIRs in NK-mediated innate immunity is well-documented, the impact of KIRs on the T cell response in human disease is not known. Here we test the hypothesis that an individual's KIR genotype affects the efficiency of their HLA class I-mediated antiviral immune response and the outcome of viral infection. We show that, in two unrelated viral infections, hepatitis C virus and human T lymphotropic virus type 1, possession of the KIR2DL2 gene enhanced both protective and detrimental HLA class I-restricted anti-viral immunity. These results reveal a novel role for inhibitory KIRs. We conclude that inhibitory KIRs, in synergy with T cells, are a major determinant of the outcome of persistent viral infection.

    See More

External Sources

  1. DOI: 10.1371/journal.ppat.1002270
  2. WOS: 000296734300006

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel